Harmony Biosciences
Manufacturing · Pennsylvania, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
630 W Germantown Pike Ste 215, Plymouth,...Phone Number
(484) 539-9800Website
www.harmonybiosciences.comRevenue
$899.1 MillionStock Symbol
HRMYIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Harmony Biosciences
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.Explore more
Harmony Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Harmony Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Harmony Biosciences has new funding data
Product Launch: Get notified when Harmony Biosciences launches new products
Harmony Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Harmony Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Harmony Biosciences
Click to see if Harmony Biosciences had a recent Job posting/layoffs
Check if Harmony Biosciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Harmony Biosciences recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Harmony Biosciences
Compare insights from companies similar to Harmony Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Harmony Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Harmony Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Harmony Biosciences.
Harmony Biosciences financials insights
Gather financial insights about Harmony Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Other Financing Round
$270M
2019
Unspecified
$200M
2020
Debt
$200M
Stock Offering
$128M
Harmony Biosciences Tech Stack
A closer look at the technologies used by Harmony Biosciences
See more technologies
Most Recent Scoops
New Hire
Executive Move
Glenn Reicin has recently joined the organization as Chief Financial Officer. Previously, Reicin served as Senior Advisor for Eccogene.
Executive Moves, New Hire
Person-Based
Events, Pharmaceuticals
Person-Based
Events
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Harmony Biosciences News & Media
Harmony Biosciences Holdings (HRMY): One of the Best Stocks to Buy According to AI
We just covered the 10 Best Stocks to Buy Right Now According to AI and Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) ranks 10th on this list. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a commercial-stage pharmaceutical company focused on developing therapies for patients suffering from rare neurological diseases. The flagship commercial product is WAKIX (pitolisant), a first-in-class […]A beaten-down biotech just lost a meaningful backer — should you care?
Harmony Biosciences develops therapies for rare neurological disorders, with WAKIX addressing excessive sleepiness in narcolepsy patients.Harmony Biosciences Holdings (HRMY) Announces Financial Results for Q1 2026
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best healthcare stocks to buy for the long term. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) announced financial results for fiscal Q1 2026 on May 7, reporting net product revenue of $215.4 million for the quarter, delivering 17% year‑over‑year growth, and on track for full year 2026 net […]Is Harmony Biosciences Holdings, Inc. (HRMY) One of The Best Small Cap Value Stocks to Buy?
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best small-cap value stocks to buy. On April 24, H.C. Wainwright reiterated a Buy rating on Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) and a $55 price target. The bullish stance is in response to positive discussions with the company’s senior management, including President and CEO Jeff Dayno, […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Harmony Biosciences
Sign Up For FreeTo access detailed company insights
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult... Read More
